ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2012

Jan 6, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2011-12-22

Reporting Person: PERRY MICHAEL S (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option dated 12/22/2011	$4.20	2021-12-22	Common Stock (20000)		Direct

Footnotes

F1: Option vests in 48 equal monthly installments